A2

Opioid-related oversedation

Skilled pain assessment found the patient difficult to arouse and drowsy after a recent opioid dose increase, with a respiratory rate of 9 and a sedation level indicating oversedation; pain reported as 2/10. Findings indicate opioid-related respiratory depression and oversedation. The next opioid dose was held and the airway supported; emergency response was activated per protocol and naloxone administered per the standing order; the provider was notified at 10:05. The patient's level of consciousness and respiratory rate improved with intervention; serial monitoring documented pending transport, and the caregiver was informed. The event, communications, and serial assessments were documented, with follow-up to reassess the regimen and reinforce opioid safety.

A3

New neuropathic pain with deficit

Skilled pain assessment found new shooting, electric pain radiating down the left leg at 6/10 with new numbness and mild weakness in the foot; pattern constant; no prior history at this site. Findings of new radicular pain with a neurologic deficit are concerning for nerve-root or cord involvement. Provider notified at 11:30 with the pain character, the new deficit, and the distribution; order received to evaluate urgently, with instruction to activate emergency response for any bowel or bladder change or rapidly progressive weakness. The patient was kept safe and educated on red-flag symptoms; the agency coordinated the ordered evaluation. Reassessment and follow-up coordinated. (Neurologic detail in the Neurological reference.)

A4

Under-treated pain in a nonverbal patient

Skilled pain assessment of a nonverbal patient with advanced dementia found a PAINAD score of 6/10 during care: labored breathing, occasional negative vocalization, a grimacing facial expression, tense body language, and difficulty consoling. The score is above the prior baseline of 1/10 and indicates under-treated pain. Provider notified at 12:15 with the PAINAD components and the change from baseline; order received to add a scheduled analgesic and reassess. After the dose the PAINAD score fell to 2/10. The caregiver was coached on recognizing the behavioral indicators and the dosing plan; teach-back accurate. Reassessment of the PAINAD score planned next visit.

A5

Analgesic-related constipation

Skilled pain assessment found pain at goal but the patient reports no bowel movement in four days with abdominal discomfort while on a scheduled opioid; the abdomen is firm with hypoactive bowel sounds. Findings indicate opioid-induced constipation, an adverse effect requiring intervention. Provider notified at 13:00 with the bowel history and the abdominal findings; order received to start a bowel regimen and increase fluids and activity as tolerated, with instruction to escalate for severe pain, vomiting, or no response. Constipation prophylaxis, hydration, and warning signs reviewed; teach-back accurate. Reassessment of bowel function planned at the next visit.

A6

Acute severe new pain

Patient reported sudden severe abdominal pain rated 9/10 that began an hour earlier, sharp and constant, with nausea; skilled assessment found a tense abdomen, a heart rate of 104, and a blood pressure lower than baseline. Findings represent acute severe new pain inconsistent with the known condition. Emergency medical services were activated according to agency protocol; the patient was kept calm with nothing by mouth while awaiting EMS, and serial vital signs were documented. The provider was notified and family present were informed; the event, communications, and serial vital signs were documented pending transport, with follow-up to coordinate care on return home.